Drug Database
MV

MV-130 (Bactek / MV130)

✓ Approved

Inmunotek · 细胞治疗 · 细胞治疗

什么是 MV-130?

MV-130 是一种细胞治疗,由Inmunotek研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)、Sublingual (SL)/Oral Transmucosal。

药物档案

商品名Bactek, MV130
公司Inmunotek
药物类别细胞治疗, 疫苗
给药途径Oral (PO), Sublingual (SL)/Oral Transmucosal
状态Approved

治疗适应症

MV-130 针对 11 个适应症,涉及 4 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsViral upper respiratory tract infection✓ Approved
Infections and infestationsLower respiratory tract infectionPhase III
Infections and infestationsOtitis mediaPhase II
Infections and infestationsPneumoniaPhase II
Infections and infestationsSinusitisPhase II

注册免费账户还可查看另外 6 个适应症

免费注册查看全部适应症 →

相关研究文献

PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Incidence of infective endocarditis following surgical or transcatheter mitral valve repair or replacement: a systematic review and meta-analysis.

Vibhishanan Jonathan J, Zorman Mark M, Malik Basimah B, Coronelli Marco M et al.

Infective endocarditis (IE) is a serious and potentially fatal complication of mitral valve (MV) intervention. There are limited data comparing the incidence of IE after MV repair compared with bioprosthetic MV replacement. The aim of this study was to analyse the incidence and timing of IE after MV repair compared with bioprosthetic valve replacement, in both surgical and transcatheter patient populations. A literature search of Medline, Embase, and Cochrane Library (January 2000-September 2025) was conducted. Pooled IE incidence rates were derived using random-effects models. Eighty-two studies (80 939 patients, total follow-up 350 252 patient-years) were included. The overall incidence rate of IE was 0.97 per 100-patient-years (95% confidence interval [CI] 0.71-1.34). IE was more common after surgical MV replacement (SMVR) than surgical MV repair (SMVr): incidence rate 0.93 (95% CI 0.41-1.81) vs 0.39 (95% CI 0.25-0.62) per 100-patient-years, incidence rate ratio (IRR) 2.34 (95% CI 1.06-5.18), P = .035. The incidence of IE after transcatheter MV replacement (TMVR) was comparable to transcatheter MV repair (TMVr) (2.88 [95% CI 1.91-4.33] vs 1.70 [95% CI 0.84-3.43] per 100-patient-years), IRR 1.56 (95% CI 0.73-3.34), P = .250. The cumulative incidence of IE following SMVR was significantly higher than following SMVr at 1- and 2-years post-procedure, but not at 6 months. IE is an infrequent complication of mitral valve intervention. The incidence of IE following SMVR is significantly higher than following SMVr, while the incidence of IE following TMVR is numerically but not significantly higher than following TMVr. Reducing IE risk after mitral intervention is a clinical and research priority.

PMID 43053862
阅读全文 →
PubMedBMC ophthalmology2026-11-19

Thirty-six-month outcomes of femtosecond laser-assisted DSEK and PKP for corneal endothelial decompensation.

Xu Siqi S, Li Yanmin Y, Wang Meihuan M, Cao Xueqian X et al.

To describe and compare the 36-month outcomes associated with femtosecond laser-assisted Descemet stripping endothelial keratoplasty (FS-DSEK) and femtosecond laser-assisted penetrating keratoplasty (FS-PKP) for corneal endothelial decompensation under indication-based surgical selection. This single-center, retrospective, nonrandomized cohort study included 130 consecutive eyes of 130 patients who underwent FS-DSEK or FS-PKP at Nanjing First Hospital, Nanjing Medical University, between July 2016 and June 2021. All included eyes had 36 months of follow-up, with data collection completed in June 2024. Procedure selection was based on pathological depth and the severity of corneal structural involvement. Visual acuity, central corneal thickness (CCT), ocular discomfort symptoms, refractive parameters, endothelial biomarkers, graft survival, and postoperative complications were evaluated. Longitudinal outcomes were analyzed using generalized estimating equations, and graft survival was estimated using Kaplan-Meier analysis. Baseline demographic, preoperative ocular, donor-related, and recorded indication variables did not differ significantly between groups. The median time to corneal transparency was shorter in the FS-DSEK group than in the FS-PKP group [4.0 (3.0, 5.25) vs. 5.0 (4.0, 7.0) days, P = 0.008]. Both groups showed improvement in ocular discomfort and CCT during follow-up. FS-DSEK was associated with more rapid early-to-intermediate improvement in uncorrected and best-corrected visual acuity, whereas visual outcomes were similar by 36 months. Spherical equivalent remained stable in both groups, while absolute astigmatism was lower after FS-DSEK. Endothelial cell density decreased in both groups; early-to-intermediate endothelial cell loss was greater after FS-DSEK and the difference was no longer statistically significant at 24 or 36 months. The 36-month graft survival rates were 86.7% and 75.8% in the FS-DSEK and FS-PKP groups, respectively, without a significant difference (P = 0.198). Graft dislocation occurred only in the FS-DSEK group. In this indication-based cohort, FS-DSEK was associated with faster corneal clearance, earlier visual recovery, and lower postoperative absolute astigmatism in eyes whose anterior stroma was expected to regain transparency. FS-PKP remained necessary for eyes with irreversible stromal opacity, scarring, degeneration, or full-thickness structural defects. The findings support complementary, anatomy-based procedure selection with procedure-specific postoperative surveillance.

PMID 43052873
阅读全文 →
PubMedAJE advances : research in epidemiology2026-11-19

Assessing the broader impact of influenza: a meta-analysis of cause-specific and all-cause influenza-associated mortality.

Wong Jessica Y JY, Cheung Justin K JK, Wu Jiaxin S JS, Choi Sammi S et al.

The mortality impact of influenza epidemics is often quantified via increases in respiratory mortality, but this may not fully capture other health outcomes like cardiovascular events. We aimed to explore the ratios of influenza-associated cause-specific to all-cause mortality. We reviewed relevant articles from PubMed and EMBASE which reported both influenza-associated all-cause mortality and at least 1 death grouping: pneumonia and influenza (P&I), respiratory, or respiratory plus cardiovascular (R + C) diseases. Only population-based estimates from influenza seasons were included. We included 130 mortality ratio estimates from 54 studies. We identified substantial heterogeneity in estimates (0.012-0.93). Higher ratio estimates were attributed to R + C diseases (0.45-0.93) compared with respiratory diseases (0.078-0.66) or P&I (0.012-0.38). Respiratory mortality to all-cause mortality ratios increased substantially with age. Our review quantifies the broader mortality burden of influenza, with substantial impact associated with cardiovascular deaths in addition to influenza-associated respiratory deaths.

PMID 43053809
阅读全文 →
PubMedDiscover nano2026-11-19

Development of nano-based HaNPV formulations for enhanced UV tolerance ability.

Sonone M V MV, Moharil M P MP, Ingle Avinash P AP, Saxena Shreshtha S et al.

A nuclear polyhedrosis virus (HaNPV) is an important biocontrol agent used against Helicoverpa armigera, a polyphagous pest on various crops. However, its persistence in the field and inactivation due to UV components from sunlight are one of the major concerns. In the present study, an attempt was made to enhance the UV tolerance ability of HaNPV by augmenting it with biogenic zinc oxide nanoparticles (ZnONPs). The ZnONPs were biologically synthesized using Moringa oleifera leaf extract. Thus, synthesized ZnONPs showed an absorbance peak at 368 nm, confirming the primary indication towards their synthesis. Moreover, further characterization performed using Nanoparticle Tracking and Analysis (NTA) revealed an average size of 31 nm, and the zeta potential measurement value was found to be -19.3 mV, predicting the stability of the ZnONPs. Further, these biogenic ZnONPs were evaluated for UV protection ability with HaNPV through different nanoformulations. The nano-based HaNPV formulation was found to retain 88.08% of original toxicity and 82.96% of original polyhedral occlusion bodies (POB) count after augmenting 80 µl ZnONPs per ml of HaNPV formulation after 15 min of UV exposure. This eco-friendly approach could be highly effective in enhancing the UV protection ability of HaNPV and thereby in the sustainable management of plant pathogens.

PMID 43052458
阅读全文 →
PubMedCommunications biology2026-11-19

Bomb-radiocarbon validated otoliths reveal 130-year lifespans and declining recruitment for blue sucker Cycleptus elongatus of the Upper Missouri River, Montana, USA.

Lackmann Alec R AR, Andrews Allen H AH, Holmquist Luke M LM, Haghipour Negar N et al.

Validated age-based life history traits are crucial towards understanding the biological complexity of the natural world. The blue sucker Cycleptus elongatus is a migratory freshwater fish of the family Catostomidae native to North America. For decades, there has been conservation concern for the species across much of its range, including populations with skewed size distributions indicative of recruitment bottlenecks. Nonetheless, no validated age-based life history information exists for the species, which is a major knowledge gap. Using thin-sectioned otoliths validated by bomb radiocarbon dating we found that individual blue sucker often live more than 100 years, exhibit sexually-size dimorphic growth, increased fecundity with size, and spot-pigmentation with age. Across 42 individuals from the Upper Missouri River, Montana, we observed a maximum lifespan of 131 years, which is 70 years older than previously reported. Furthermore, 64-76% of individuals were from hatch years that pre-date the completion of Fort Peck Dam (1940), Canyon Ferry Dam (1954), and Tiber Dam (1956), which suggests recruitment failure is more likely in the post-dam era. Our findings redefine our understanding of blue sucker, parallel recent population demographic discoveries for buffalofishes (Ictiobus spp.), and further identify the diversity of the centenarian catostomid guild.

PMID 43052453
阅读全文 →
PubMedPlant foods for human nutrition (Dordrecht, Netherlands)2026-11-19

Harnessing the Antibacterial Potential of Star Fruit Extract against MRSA: Metabolic Profiling, Molecular Docking, and In Vitro Wound-Healing Effects.

Eraqi Walaa A WA, Mohamed Sally A SA, Hanafi Maha M, Salem Mohamed A MA et al.

Averrhoa carambola L. (star fruit) is recognized for its nutritional value and bioactive constituents. This study investigated its antibacterial and antibiofilm activities against methicillin-resistant Staphylococcus aureus (MRSA) and its potential to promote wound healing. The in vitro antibacterial activity of the extract was evaluated against six MRSA strains by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill kinetics. The extract exhibited a uniform MIC of 1.95 mg/mL against all tested MRSA strains, while MBC values ranged from 15.6 to 125 mg/mL. Biofilm inhibition was assessed using a crystal violet assay, while transmission electron microscopy and intracellular ion leakage analysis were used to investigate the antibacterial mechanism. The extract significantly inhibited biofilm formation at 0.5 × and 0.25 × MIC, particularly against MS3 and MS15 strains (p ≤ 0.05). The extract induced membrane damage and significant leakage of intracellular phosphate (p = 0.0036) and potassium (p = 0.0001). Its cytocompatibility and wound-healing activity were evaluated using primary human adult dermal fibroblasts (HDFa) and an in vitro scratch assay. The extract showed an EC50 of 2.96 mg/mL without reducing HDFa viability and significantly enhanced wound closure to 70%, compared with 82% for dexamethasone. UPLC-QTOF-MS/MS profiling identified 130 metabolites, with flavonoids representing the predominant class (49 compounds). Molecular docking further predicted favorable binding interactions between selected flavonoids and collagenase, elastase, and lipase. These findings demonstrate the antibacterial, antibiofilm, and in vitro wound-healing potential of star fruit extract against MRSA.

PMID 43052601
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多MV-130